Paul, Weiss, Rifkind, Wharton & Garrison LLP handles the full spectrum of tech and life sciences patent disputes, spanning jury and bench trials as well as appeals at the Federal Circuit. The department is further distinguished by its ‘top-notch’ antitrust and trade secret offering. In New York, the team is co-chaired by Brad Karp, Jessica Carey and Catherine Nyarady. Nyarady is a prominent patent litigator with expertise in medical devices, semiconductors and pharma. In Washington DC, Kannon Shanmugam, a leading appellate litigator, chairs the team. Elizabeth Stotland Weiswasser frequently takes on the role of lead counsel in high-stakes pharma and biotech patent disputes, while Katherine Forrest handles patent and antitrust litigation related to AI, cryptocurrency and blockchain. Crystal Parker brings valuable expertise in Hatch-Waxman litigation, biologics and medical devices. Additionally, Kripa Raman further strengthens the team’s capabilities with his experience in patent and trade secret litigation. Karen Dunn, Bill Isaacson, and Jeannie S. Rhee have departed the firm.
L'éditorial du Legal 500
Distinctions
La satisfaction du client: Qualité de l’avocat et de l’équipe
La satisfaction du client: Connaissance du secteur
Témoignages
Collectés indépendamment par l'équipe de recherche du Legal 500.
‘Paul Weiss has a top-notch antitrust trial team.’
‘Really great team to work with. The right mixture of different backgrounds, experience and levels of seniority. Overall, pragmatic and hands-on approach. ’
Clients clés
- Atos Syntel
- iFlight Technology Company Limited
- International Business Machines Corporation (IBM)
- Kurin, Inc.
- Leading Audio and Visual Technology Company
- Markforged
- Qualcomm Incorporated
- SAP AG
Responsable de la pratique
Brad Karp; Jessica Carey; Kannon Shanmugam; Catherine Nyarady
Autres avocats clés
Elizabeth Stotland Weiswasser; Katherine Forrest; Crystal Parker; Kripa Raman